T. Tefre

发表

GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.

D. Ryberg, A. Haugen, A. Børresen, 2000, Carcinogenesis.

Differences in serum levels of CB-153 and p,p'-DDE, and reproductive parameters between men living south and north in Norway.

L. Hagmar, A. Giwercman, L. Rylander, 2011, Reproductive toxicology.

Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.

A. Brøgger, D. Ryberg, V. Skaug, 1991, Pharmacogenetics.

Inhibition of very-low-density lipoprotein secretion by chloroquine, verapamil and monensin takes place in the Golgi complex.

C. Drevon, T. Tefre, A. C. Rustan, 1987, Biochimica et biophysica acta.

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

O. Andreassen, V. Steen, J. Idle, 1995, Pharmacogenetics.

PstI polymorphism at the human P1450 gene on chromosome 15.

A. Haugen, A. Børresen, T. Tefre, 1990, Nucleic acids research.

Ha-ras-1 alleles in Norwegian lung cancer patients

D. Ryberg, V. Skaug, L. Stangeland, 1990, Human Genetics.

Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.

D. Ryberg, V. Skaug, L. Stangeland, 1992, Environmental health perspectives.

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence

A. Børresen-Dale, S. Fosså, V. Kristensen, 2007, Radiation oncology.

Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.

A. Brøgger, S. Aamdal, A. Børresen, 1990, British Journal of Cancer.

Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls.

A. Brøgger, J. Idle, A. Børresen, 1994, Pharmacogenetics.